The new generation of antidepressants.
D000525:Alprazolam; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D001977:Brompheniramine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016642:Bupropion; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D011427:Propiophenones / Q000627:therapeutic use; D015031:Zimeldine
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D011427:Propiophenones; D005473:Fluoxetine; D016642:Bupropion; D001569:Benzodiazepines; D015031:Zimeldine; D001977:Brompheniramine; D000525:Alprazolam